合計 50 件の最近のインサイダー取引記録が記録されています HOOKIPA Pharma Inc. (HOOK), 内訳は 44 件の買い および 2 件の売り. インサイダー買い総額は $4.56M インサイダー売り総額は $29.48K.
最近活動のある主要インサイダーには Cassidy Sean A, Coelho Mary Theresa, Peters Malte. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — HOOK
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-07-22 |
Cassidy Sean A |
Officer |
不明 |
- |
- |
- |
- |
| 2024-07-22 |
Cassidy Sean A |
Director |
RSU 付与（制限付株式） |
9,800 |
$6.44 |
$63.11K |
9,800 |
| 2024-07-22 |
Coelho Mary Theresa |
EVP and CFO |
RSU 付与（制限付株式） |
69,875 |
- |
- |
69,875 |
| 2024-07-22 |
Peters Malte |
Chief Executive Officer |
RSU 付与（制限付株式） |
108,695 |
- |
- |
108,695 |
| 2024-06-17 |
O'neill Julie |
Director |
RSU 付与（制限付株式） |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Coelho Mary Theresa |
Director |
RSU 付与（制限付株式） |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Van De Winkel Jan |
Director |
RSU 付与（制限付株式） |
98,000 |
$0.71 |
$69.58K |
98,000 |
| 2024-06-17 |
Kaufman David Ross |
Director |
RSU 付与（制限付株式） |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Peters Malte |
Director |
RSU 付与（制限付株式） |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Reilly Timothy P. |
Director |
RSU 付与（制限付株式） |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-04-15 |
Aldag Jorn |
Chief Executive Officer |
RSU 付与（制限付株式） |
971,400 |
$0.76 |
$738.26K |
971,400 |
| 2024-04-15 |
Kandera Reinhard |
Chief Financial Officer |
RSU 付与（制限付株式） |
406,200 |
$0.76 |
$308.71K |
406,200 |
| 2024-04-15 |
Orlinger Klaus |
Chief Scientific Officer |
RSU 付与（制限付株式） |
367,300 |
$0.76 |
$279.15K |
367,300 |
| 2024-04-15 |
Necina Roman |
Chief Operations Officer |
RSU 付与（制限付株式） |
367,300 |
$0.76 |
$279.15K |
367,300 |
| 2024-04-15 |
Winderlich Mark |
Chief Development Officer |
RSU 付与（制限付株式） |
50,000 |
$0.76 |
$38K |
50,000 |
| 2024-04-01 |
Winderlich Mark |
Officer |
不明 |
- |
- |
- |
- |
| 2023-12-20 |
Gilead Sciences, Inc. |
10 Percent Owner |
処分 |
- |
- |
- |
18,759,465 |
| 2023-08-21 |
Kandera Reinhard |
Chief Financial Officer |
情報に基づく買い |
7,000 |
$0.73 |
$5.08K |
43,092 |
| 2023-08-16 |
Kandera Reinhard |
Chief Financial Officer |
情報に基づく買い |
8,000 |
$0.71 |
$5.71K |
36,092 |
| 2023-07-11 |
Aldag Jorn |
Chief Executive Officer |
情報に基づく買い |
5,000 |
$0.83 |
$4.14K |
71,952 |
| 2023-07-07 |
Aldag Jorn |
Chief Executive Officer |
情報に基づく買い |
5,000 |
$0.81 |
$4.05K |
66,952 |
| 2023-07-05 |
Aldag Jorn |
Chief Executive Officer |
情報に基づく買い |
5,000 |
$0.89 |
$4.45K |
61,952 |
| 2023-07-03 |
Aldag Jorn |
Chief Executive Officer |
情報に基づく買い |
5,000 |
$0.89 |
$4.46K |
56,952 |
| 2023-06-30 |
Kandera Reinhard |
Chief Financial Officer |
情報に基づく買い |
12,000 |
$0.88 |
$10.56K |
28,092 |
| 2023-06-09 |
O'neill Julie |
Director |
RSU 付与（制限付株式） |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-06-09 |
Coelho Mary Theresa |
Director |
RSU 付与（制限付株式） |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Van De Winkel Jan |
Director |
RSU 付与（制限付株式） |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Kaufman David Ross |
Director |
RSU 付与（制限付株式） |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-06-09 |
Peters Malte |
Director |
RSU 付与（制限付株式） |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Reilly Timothy P. |
Director |
RSU 付与（制限付株式） |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-04-14 |
Aldag Jorn |
Chief Executive Officer |
RSU 付与（制限付株式） |
513,600 |
$1.00 |
$513.6K |
513,600 |
| 2023-04-14 |
Kandera Reinhard |
Chief Financial Officer |
RSU 付与（制限付株式） |
214,800 |
$1.00 |
$214.8K |
214,800 |
| 2023-04-14 |
Orlinger Klaus |
Chief Scientific Officer |
RSU 付与（制限付株式） |
194,200 |
$1.00 |
$194.2K |
194,200 |
| 2023-04-14 |
Necina Roman |
Chief Development Officer |
RSU 付与（制限付株式） |
112,100 |
$1.00 |
$112.1K |
112,100 |
| 2023-04-14 |
Baker Christine D. |
Chief Operating Officer |
RSU 付与（制限付株式） |
275,800 |
$1.00 |
$275.8K |
275,800 |
| 2023-04-14 |
Schlienger Katia |
Chief Medical Officer |
RSU 付与（制限付株式） |
184,000 |
$1.00 |
$184K |
184,000 |
| 2023-04-03 |
Coelho Mary Theresa |
Director |
不明 |
- |
- |
- |
- |
| 2023-03-09 |
Schlienger Katia |
Chief Medical Officer |
処分 |
17,760 |
$1.66 |
$29.48K |
- |
| 2023-01-01 |
Peters Malte |
Director |
不明 |
- |
- |
- |
- |
| 2022-06-30 |
O'neill Julie |
Director |
RSU 付与（制限付株式） |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Aldag Jorn |
Chief Executive Officer |
RSU 付与（制限付株式） |
275,250 |
$1.66 |
$456.92K |
275,250 |
| 2022-06-30 |
Van De Winkel Jan |
Director |
RSU 付与（制限付株式） |
40,000 |
$1.63 |
$65.2K |
40,000 |
| 2022-06-30 |
Matushansky Igor |
Chief Medical Officer |
RSU 付与（制限付株式） |
92,950 |
- |
- |
92,950 |
| 2022-06-30 |
Kandera Reinhard |
Chief Financial Officer |
RSU 付与（制限付株式） |
92,950 |
$1.66 |
$154.3K |
92,950 |
| 2022-06-30 |
Orlinger Klaus |
Chief Scientific Officer |
RSU 付与（制限付株式） |
48,350 |
$1.66 |
$80.26K |
48,350 |
| 2022-06-30 |
Kelly Michael Aaron |
Director |
RSU 付与（制限付株式） |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Kaufman David Ross |
Director |
RSU 付与（制限付株式） |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Necina Roman |
Chief Technology Officer |
RSU 付与（制限付株式） |
48,350 |
$1.66 |
$80.26K |
48,350 |
| 2022-06-30 |
Baker Christine D. |
Chief Operating Officer |
RSU 付与（制限付株式） |
100,000 |
- |
- |
100,000 |
| 2022-06-30 |
Reilly Timothy P. |
Director |
RSU 付与（制限付株式） |
40,000 |
- |
- |
40,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
